Cellular Intelligence Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
42
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$60M
- Investors
-
33
Cellular Intelligence General Information
Description
Developer of a biotechnology platform designed to transform medical treatments, diseases, and therapeutic research approaches. The company's platform utilizes artificial intelligence to integrate and analyze vast amounts of biological, genetic, and clinical data to uncover insights into diseases, cell functions, and treatment responses, enabling research and pharmaceutical companies to accelerate the development and optimization of cell therapies.
Contact Information
Website
www.cellularintelligence.comCorporate Office
- 240 Longwood Avenue
- Suite 125, Building C on the Harvard Medical School Quad
- Boston, MA 02115
- United States
Corporate Office
- 240 Longwood Avenue
- Suite 125, Building C on the Harvard Medical School Quad
- Boston, MA 02115
- United States
Cellular Intelligence Timeline
Cellular Intelligence Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A1) | 20-Aug-2025 | $60M | Completed | Generating Revenue | ||
| 3. Seed Round | 09-Sep-2024 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Cellular Intelligence Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 4,856,414 | $0.000010 | $1.1 | $1.1 | 1x | $1.1 | 10.58% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Cellular Intelligence Comparisons
Industry
Financing
Details
Cellular Intelligence Competitors (3)
One of Cellular Intelligence’s 3 competitors is bit.bio, a Venture Capital-Backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| bit.bio | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Deepcell | Venture Capital-Backed | Menlo Park, CA | ||||
| Myogenica | Venture Capital-Backed | Dover, DE |
Cellular Intelligence Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cellular Intelligence Patents
Cellular Intelligence Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026161887-A1 | Capsule and single-cell combinatorial barcoding | Pending | 27-Jan-2025 | ||
| EP-4735585-A1 | Enhancing neuronal differentiation of neural progenitor cells | Pending | 30-Jun-2023 | ||
| EP-4680963-A1 | Biological methods | Pending | 17-Mar-2023 | ||
| US-20260266818-A1 | Biological methods | Pending | 17-Mar-2023 | ||
| EP-4547825-A1 | Enhancing neuronal differentiation of ventral midbrain neural progenitor cells | Pending | 01-Jul-2022 | C12N5/0619 |
Cellular Intelligence Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cellular Intelligence Investors (33)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ajinomoto | Corporation | Minority | ||
| AMD Ventures | Corporate Venture Capital | Minority | ||
| ByTheTower | Venture Capital | Minority | ||
| Chan Zuckerberg Initiative | Impact Investing | Minority | ||
| Etna Labs | VC-Backed Company | Minority |
Cellular Intelligence Investments (1)
Cellular Intelligence’s most recent deal was a Corporate Asset Purchase with Novo Nordisk (Global Rights of Parkinson's Cell Therapy in Bagsvaerd, Denmark). The deal was made on 11-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Novo Nordisk (Global Rights of Parkinson's Cell Therapy in Bagsvaerd, Denmark) | 11-May-2026 | Corporate Asset Purchase | Buildings and Property |
Cellular Intelligence FAQs
-
When was Cellular Intelligence founded?
Cellular Intelligence was founded in 2023.
-
Where is Cellular Intelligence headquartered?
Cellular Intelligence is headquartered in Boston, MA.
-
What is the size of Cellular Intelligence?
Cellular Intelligence has 42 total employees.
-
What industry is Cellular Intelligence in?
Cellular Intelligence’s primary industry is Drug Discovery.
-
Is Cellular Intelligence a private or public company?
Cellular Intelligence is a Private company.
-
What is the current valuation of Cellular Intelligence?
The current valuation of Cellular Intelligence is .
-
What is Cellular Intelligence’s current revenue?
The current revenue for Cellular Intelligence is .
-
How much funding has Cellular Intelligence raised over time?
Cellular Intelligence has raised $70.3M.
-
Who are Cellular Intelligence’s investors?
Ajinomoto, AMD Ventures, ByTheTower, Chan Zuckerberg Initiative, and Etna Labs are 5 of 33 investors who have invested in Cellular Intelligence.
-
Who are Cellular Intelligence’s competitors?
bit.bio, Deepcell, and Myogenica are competitors of Cellular Intelligence.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
